Myofibroma: all 344 studies

Page 3 of 4. Open to participants first (41), then studies with results posted, then the rest; newest registration first within each.

• Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents.CompletedNCT03072446Not applicable
• Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03070951Phase 3
• Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedNCT03070899Phase 3
• Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ SystemCompletedNCT03028610Not applicable
• Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization TrialCompletedNCT03021720Not applicable
• Transverse vs Longitudinal Incision in MyomectomyCompletedNCT03009812Not applicable
• High-intensity Focused Ultrasound in Treatment of Uterine FibroidCompletedNCT02954744Not applicable
• Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave TreatmentStatus unknownNCT02942537Phase 2/3
• Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)CompletedNCT02889848Phase 1
• Safety and Efficacy of Embozene Microspheres for Uterine Fibroid EmbolizationStatus unknownNCT02884960Not applicable
• Intraoperative Ultrasound in Laparoscopic or Robotic Myomectomy PatientsTerminatedNCT02879058Not applicable
• The Effect of Anesthetic Technique on VEGF-C and PGE2CompletedNCT02829333Not applicable
• Ulipristal Use in Chinese PopulationTerminatedNCT02825719Phase 4
• Comparing Patient-Centered Outcomes After Treatment for Uterine FibroidsCompletedNCT02819609
• Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused UltrasoundWithdrawnNCT02736435Phase 3
• Radio Frequency Ablation (RFA STUDY )Status unknownNCT02631278Not applicable
• Fibroids in Women of Reproductive Age and Women PregnancyCompletedNCT02620345Phase 4
• IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF FailureStatus unknownNCT02601196Phase 4
• A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine FibroidsCompletedNCT02580578
• Does Preventive Uterine Artery Occlusion During Laparoscopic Myomectomy Impact on Ovarian Reserve Markers?CompletedNCT02563392Not applicable
• Optimal Order of Concurrent Office Hysteroscopy and Endometrial BiopsyCompletedNCT02472184Not applicable
• Assess Safety and Efficacy of Vilaprisan in Patients With Uterine FibroidsCompletedNCT02465814Phase 2
• Ulipristal Acetate 10 mg and Asisted ReproductionTerminatedNCT02425878Phase 3
• Single or Triple Uterine Tourniquet at MyomectomyCompletedNCT02392585Not applicable
• South Miami Hospital Fibroid RegistryTerminatedNCT02362009
• Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular LeiomyomasStatus unknownNCT02361905Phase 4
• Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine LeiomyomaStatus unknownNCT02361879Phase 4
• Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid EmbolizationCompletedNCT02293447Phase 4
• Clinical Test of the MRgHIFU System on Uterine FibroidsStatus unknownNCT02283502Phase 1
• Patient Centered Results for Uterine FibroidsCompletedNCT02260752
• Patient-Controlled Epidural Analgesia After Uterine Artery EmbolizationStatus unknownNCT02236585Not applicable
• Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine FibroidsCompletedNCT02189083Phase 3
• Vascular Function and Uterine FibroidsCompletedNCT02123069
• Intracorporeal Versus Extracorporeal Morcellation: Clinical Efficacy and Safety OutcomesCompletedNCT02086435Not applicable
• Vaginal vs. Laparoscopic HysterectomyCompletedNCT02059954Not applicable
• Use of Dexamethasone in Uterine Artery EmbolizationCompletedNCT02056717Not applicable
• Uterine Tourniquet at Open MyomectomyCompletedNCT02049242Not applicable
• Long Term Prevention of Nausea and Vomiting in Gynecologic LaparoscopyStatus unknownNCT02011659Phase 3
• Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF AblationTerminatedNCT01998854
• Barbed Suture in Single-port Laparoscopic MyomectomyCompletedNCT01984632Phase 3
• a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy.WithdrawnNCT01971060Not applicable
• ONSD According to the Position During LaparoscopyCompletedNCT01937104Not applicable
• Biologic Predictors of Leiomyoma Treatment OutcomesCompletedNCT01936493
• GnRH Agonist Pretreatment in Hysteroscopic MyomectomyCompletedNCT01873378Not applicable
• Vasopressin Versus Epinephrine in MyomectomyCompletedNCT01861015Phase 3
• Hand-assisted Laparoscopic Surgery (HALS) for MyomectomyTerminatedNCT01858454Phase 3
• Uterine Fibroid Embolization- Long Term Follow up and Technical PerspectivesCompletedNCT01852734Not applicable
• Uterine Leiomyoma Treatment With Radiofrequency AblationCompletedNCT01840124Not applicable
• Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine FibroidsTerminatedNCT01834703Not applicable
• Mifepristone to Treat Uterine FibroidsTerminatedNCT01786226Phase 2/3
• ESTD vs. VATS for Upper Gastrointestinal Submucosal TumorsStatus unknownNCT01768104Not applicable
• Laparoscopic Uterine Sparing Techniques Outcomes and ReinterventionsCompletedNCT01750008Not applicable
• Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological SurgeryCompletedNCT01745432Phase 1
• Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200CompletedNCT01739621Phase 2
• Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and GoserelinTerminatedNCT01738724Phase 4
• Laparoscopic Cryoablation of Uterine FibroidsWithdrawnNCT01735812Not applicable
• Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine MyomaCompletedNCT01715597Phase 3
• Endometrial and Myometrial Changes, With and Without FibroidsWithdrawnNCT01671215
• Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic SurgeryStatus unknownNCT01637974Not applicable
• A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine FibroidsStatus unknownNCT01635452
• Extension of Study ZPV-200CompletedNCT01631903Phase 2
• Somatic Stem Cells in Leiomyomas?CompletedNCT01592903
• China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine FibroidsCompletedNCT01588899Not applicable
• Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine LeiomyomaWithdrawnNCT01553123Phase 3
• Comparison of Robot-assisted Laparoscopic Myomectomy With Traditional Laparoscopic MyomectomyCompletedNCT01542658
• Fibroid Ablation Study - Large FibroidsTerminatedNCT01539187Not applicable
• Temporary Clipping of the Uterine Arteries During Laparoscopic MyomectomyCompletedNCT01530802Not applicable
• Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery EmbolizationActive, not recruitingNCT01514617Not applicable
• Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine FibroidsTerminatedNCT01504308Phase 2/3
• Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.CompletedNCT01492179Phase 4
• Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic HysterectomyStatus unknownNCT01483417Phase 3
• Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine LeiomyomaCompletedNCT01468402
• Electronic Catheter StethoscopeCompletedNCT01463462
• Efficacy and Safety of TAK-385 in the Treatment of Uterine FibroidsCompletedNCT01452659Phase 2
• The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg PositionCompletedNCT01379313Not applicable
• Magnetic Resonance Guided Focused Ultrasound for Uterine FibroidsCompletedNCT01377519Not applicable
• Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast CancerCompletedNCT01338831Phase 1
• Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine FibroidsWithdrawnNCT01328067Not applicable
• Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine FibroidsTerminatedNCT01311869Phase 2
• Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal HysterectomyTerminatedNCT01280045Not applicable
• Clinical Database and Biobank of Patients With Gynecologic NeoplasmsStatus unknownNCT01267851
• High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine FibroidsStatus unknownNCT01239641Phase 4
• Magnetic Resonance Elastography (MRE) of Uterine FibroidsCompletedNCT01229826
• Fibroid Ablation StudyTerminatedNCT01226290Not applicable
• Therapeutic MRI Guided High Intensity Focused Ultrasound Ablation of Uterine FibroidsCompletedNCT01141062Phase 3
• A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO DeviceTerminatedNCT01140555Not applicable
• Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine LeiomyomataCompletedNCT01123603
• A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine FibroidsCompletedNCT01092988Not applicable
• A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic LeiomyomataCompletedNCT01069094Phase 1/2
• Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI ScannerCompletedNCT01064960Phase 3
• Study of Different Pain Scores in Single-Port Access (SPA) Laparoscopic Hysterectomy Versus Conventional Laparoscopic HysterectomyCompletedNCT01064128Phase 3
• Single-port Access Laparoscopic-assisted Vaginal HysterectomyStatus unknownNCT01048931Phase 3
• The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.CompletedNCT00995878Phase 4
• Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal SystemCompletedNCT00979342Not applicable
• Aromatase Inhibitors for Treatment of Uterine LeiomyomasWithdrawnNCT00945360Phase 1
• Robot-Assisted Laparoscopic Myomectomy Is an Improvement Over Laparotomy in Patients With a Limited Number of FibroidsCompletedNCT00910468
• Mifepristone 10 or 5 mg for 6 Months to Treat Uterine FibroidsCompletedNCT00886873Phase 2/3
• Study of Proellex in Pre-menopausal Women With Symptomatic Uterine FibroidsCompletedNCT00882258Phase 2
• Efficacy Study of Vaginal Mifepristone to Treat Uterine FibroidsCompletedNCT00881140Phase 2
• Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid SymptomsWithdrawnNCT00874302Phase 3

← Myofibroma overview